Trials / Unknown
UnknownNCT02267980
Effect of the Addition of Ketamine to Sevoflurane Anesthesia in Electroconvulsive Therapy
Turgut Ozal Medical Center Department of Anesthesiology and Reanimation
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Inonu University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The investigators evaluate the effects of a subanesthetic dose of ketamine, administered as an adjunct to sevoflurane, on duration of seizure activity, hemodynamic profile and recovery times during electroconvulsive therapy (ECT) in patients with major depression.
Detailed description
Patients will randomly allocate, to either a sevoflurane-ketamine (Group SK), sevoflurane-saline (Group SS) receiving group. Mean arterial pressure (MAP) and heart rate (HR) will record prior to anesthetic induction (T1); following anesthetic induction (T2); and 0, 1, 3, and 10 min after the seizure has ended (T3, T4, T5, and T6, respectively). Motor and EEG seizure durations will be recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevoflurane | Inhalation anesthetic agent |
| DRUG | Ketamine | Intravenous anesthetic agent |
| DRUG | Saline | Isotonic solution for placebo group |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2014-10-01
- Completion
- 2014-10-01
- First posted
- 2014-10-20
- Last updated
- 2014-10-20
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT02267980. Inclusion in this directory is not an endorsement.